- New
Ipamorelin / CJC-1295 mix 5mg + 5mg
€40.99
Ipamorelin / CJC 1295 Blend 10mg (5mg + 5mg) research-grade lyophilized peptide powder in a glass vial. This blend combines the selective ghrelin receptor agonist Ipamorelin with CJC-1295 (no DAC, Mod GRF 1-29), a Growth Hormone Releasing Hormone (GHRH) analog, studied in experimental models of pituitary function and growth hormone (GH) secretion dynamics.
Research Use Only: Laboratory research use only. Not for human or veterinary use.
Third-Party Tested
This product is third-party tested — view the certificate of analysis and laboratory verification.
Recommended solvent — Bacteriostatic water
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water.
Research Overview
The Ipamorelin / CJC-1295 (no DAC) Blend 10mg (5mg + 5mg) combines two complementary growth hormone secretagogues: Ipamorelin, a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R), and CJC-1295 (no DAC), a modified GHRH analog (Mod GRF 1-29). In experimental endocrinology, this dual-agonist blend is used as a tool compound to investigate GH/IGF-1 axis regulation, pituitary signaling and pulsatile growth hormone secretion patterns in in vitro and in vivo research models.
Primary Research Areas
- Growth hormone secretion dynamics: Laboratory models exploring synergistic GH release via concurrent activation of GHS-R by Ipamorelin and GHRH receptors by CJC-1295 (no DAC), including studies of GH pulse amplitude and frequency.
- Pituitary and hypothalamic signaling: Experiments evaluating downstream intracellular pathways in pituitary somatotrophs and hypothalamic circuits in response to combined ghrelin receptor and GHRH receptor stimulation.
- GH/IGF-1 axis modulation: Preclinical research assessing how the blend influences growth hormone and insulin-like growth factor 1 (IGF-1) patterns in controlled endocrine models, without implying any therapeutic or performance outcomes.
- Endocrine feedback and receptor interactions: Studies focused on feedback regulation, receptor desensitization and cross-talk between ghrelin, GHRH and somatostatin pathways under dual-secretagogue stimulation.
- Method development and assay calibration: Use of the Ipamorelin / CJC-1295 blend as a reference tool in assay development, bioanalytical method validation and mechanistic GH secretion research in vitro and in vivo.
Lab data
| Purity: | High-purity research grade |
| Form: | Lyophilized peptide powder |
| Content: | 5mg Ipamorelin & 5mg CJC-1295 (no DAC) per vial |
| Packaging: | Glass vial with sterile closure |
| Storage: | Store lyophilized at 2–8 °C (desiccated, protect from light) |
| Molecular formula: | Mixture |
| Molecular weight: | Mixture |
| Sequences: | Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 CJC-1295 (no DAC): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| CAS numbers: | 170851-70-4 (Ipamorelin) 863288-34-0 (CJC-1295 no DAC) |
Warning
This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.
Comments (0)
No customer reviews for the moment.
